KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB:PVCT, http://www.pvct.com) has begun recruiting patients for the Phase 2 clinical trial of topical PH-10 for the treatment of psoriasis, and has commenced treatment of the first patient.
